BEGIN:VCALENDAR
VERSION:2.0
PRODID:PHP
BEGIN:VEVENT
DTSTART:20210601
SUMMARY:OICR Jlabs Cancer Symposium
DESCRIPTION:<p>On June 1, 2021, Zenith presented&nbsp;at the&nbsp;OICR Jlabs Cancer Symposium with regards to the&nbsp;clinical development of the BET bromodomain inhibitor ZEN-3694 in multiple oncology indications.</p>
END:VEVENT
END:VCALENDAR